Active substance
Charcoal activated
- Health Canada 10
- UK MHRA 3
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACTIVATED CHARCOAL | 02236563 | 225 MG | CAPSULE · ORAL | LABORATOIRE LEO DESILETS M.H. INC |
| ACTIVATED CHARCOAL | 02420694 | 225 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| ACTIVATED CHARCOAL 260MG | 00789674 | 260 MG | CAPSULE · ORAL | EXZELL PHARMA INC |
| ACTIVATED CHARCOAL CAPSULES | 02504723 | 250 MG | CAPSULE · ORAL | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. |
| ACTIVATED CHARCOAL CAPSULES | 02537680 | 250 MG | CAPSULE · ORAL | BIOCLINIC NATURALS INC. |
| CHARAC-25 | 02056429 | 222 MG / ML | SUSPENSION · ORAL | OMEGA LABORATORIES LIMITED |
| CHARAC-50 | 00637955 | 50 G / 225 ML | SUSPENSION · ORAL | OMEGA LABORATORIES LIMITED |
| CHARACTOL-50 | 00649236 | 50 G / 250 ML | SUSPENSION · ORAL | OMEGA LABORATORIES LIMITED |
| CHARCO CAPS | 02423715 | 260 MG | CAPSULE · ORAL | FUTURE PAK LLC |
| WAMPOLE ACTIVATED CHARCOAL | 02395517 | 225 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| CARBOMIX 50G GRANULES FOR ORAL SUSPENSION | PL 51463/0098 | KENT PHARMA UK LIMITED | P |
| J.L. BRAGG'S MEDICINAL CHARCOAL POWDER B.P.C | PL 00726/5003R | J L BRAGG (IPSWICH) LIMITED | GSL |
| J.L. BRAGG'S MEDICINAL CHARCOAL TABLETS | PL 00726/5000R | J L BRAGG (IPSWICH) LIMITED | GSL |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.